Funding and Development Progress
The allocates $590 million to for advancing influenza vaccines, including against bird flu, building on a previous $176 million support.
Moderna's efforts focus on a "pandemic influenza vaccine" targeting and H7 avian influenza viruses, with plans for phase 3 trials following positive early results.
Public Health Context and Response
Amidst a rapid spread of bird flu in the US, with 67 confirmed human cases and one death, the government prioritizes vaccine development to counter unpredictable virus variants.
The administration's broader strategy includes over $300 million for bird flu monitoring and preparedness, emphasizing the importance of collaboration for public health safety.